Please use this identifier to cite or link to this item:
Title: Are macrolides as effective as fluoroquinolones in Legionella pneumonia?: YES, But...
Author: Torres Martí, Antoni
Cillóniz, Catia
Keywords: Antibiòtics
Pneumònia adquirida a la comunitat
Infeccions nosocomials
Community-acquired pneumonia
Nosocomial infections
Issue Date: 16-Apr-2020
Publisher: Oxford University Press
Abstract: Legionella pneumonia (LP) is a well-known cause of community-acquired pneumonia (CAP) in immunocompetent patients. This intracellular pathogen is considered one of the "core microorganisms" of CAP and it is also a microorganism that can cause hospital-acquired pneumonia (HAP) either in individual cases or in the form of large-scale outbreaks. Immunosuppressed patients have a higher risk of acquiring this infection, both in the community and in the hospital, for this reason LP has to be empirically covered and intensively searched for diagnosis. Inadequate initial or delayed antibiotic treatments in LP are factors associated with a worse prognosis.
Note: Versió postprint del document publicat a:
It is part of: Clinical Infectious Diseases, 2020
Related resource:
ISSN: 1058-4838
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
701131.pdf450.96 kBAdobe PDFView/Open    Request a copy

Embargat   Document embargat fins el 31-12-2021

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.